Overview

Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)

Status:
Completed
Trial end date:
2010-11-04
Target enrollment:
Participant gender:
Summary
This study will examine whether the incidence of hypoglycemia in patients fasting for Ramadan is lower when treated with sitagliptin as compared to sulfonylurea treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Metformin
Sitagliptin Phosphate